Canada Pension Plan Investment Board Adds $258M in Astera Labs, Inc. ($ALAB)
The pension fund boosted its position in the semiconductor company by 659%, ending with 600,500 shares.
Key Points
- Canada Pension Plan Investment Board increased its Astera Labs stake by 659%, adding 521,400 shares to reach a total of 600,500 shares, valued at $244.7 million.
- Astera Labs, trading on NasdaqGS under ALAB, has a market cap of $71.5 billion and a forward P/E ratio of 99.1.
- Insiders at Astera Labs engaged in both planned and unplanned trades, with several buying shares on June 4, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
The Canada Pension Plan Investment Board (CPPIB) has significantly increased its investment in Astera Labs, Inc. (NasdaqGS: ALAB). According to the latest Form 13F filing, CPPIB boosted its position by 659%, adding 521,400 shares during the reporting period. This brings their total holdings to 600,500 shares, valued at approximately $244.7 million.
Canada Pension Plan Investment Board vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in Canada Pension Plan Investment Board's Astera Labs Position
CPPIB's move marks a substantial increase from its previous holding of 79,100 shares. The addition of 521,400 shares represents a 659% increase, demonstrating a strong vote of confidence in Astera Labs. The total value of the investment now stands at about $244.7 million, reflecting the fund's increased exposure to the semiconductor industry.
Other Institutional Activity in Astera Labs
Several other institutional investors have also adjusted their positions in Astera Labs. FMR LLC increased its holdings by 194,944 shares, ending with 25,529,885 shares valued at roughly $2.8 billion. In contrast, BlackRock, Inc. reduced its stake by 1,519,089 shares, now holding 11,449,769 shares worth about $1.25 billion. Atreides Management, LP significantly increased its position by 1,754,593 shares, bringing its total to 3,365,787 shares valued at $368.9 million. Meanwhile, State Street Corp added 233,797 shares, resulting in a total of 3,333,606 shares, valued at $365.4 million.
Astera Labs, Inc. Stock Up 66.5%
Astera Labs, Inc., trading under the ticker ALAB on the NasdaqGS, is currently priced around $407.43. The company boasts a market capitalization of $71.5 billion and a forward P/E ratio of 99.1, indicating growth expectations. The stock has a 52-week range between $84.78 and $421.20, with a 50-day moving average of $258.03 and a 200-day moving average of $186.22. Astera Labs also maintains a high current ratio of 11.3 and a quick ratio of 10.55, with a debt-to-equity ratio of 2.801.
$ALAB stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Astera Labs reported revenues of approximately $1 billion, with a robust revenue growth of 93.4%. The company's net margin stands at 26.7%, and it has a return on equity of 21.1%. The next earnings report is anticipated on August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Astera Labs, Inc.
Insider activity at Astera Labs included both planned and unplanned trades. On June 4, 2026, Jack Lazar sold 10,000 shares at an average price of $355.17 under a Rule 10b5-1 plan. On the same day, insiders Craig Barratt, Michael Hurlston, Bethany Mayer, and Stefan Dyckerhoff each purchased 837 shares in unplanned transactions.
Analysts Set New Price Targets
Analyst coverage of Astera Labs remains active. On May 19, 2026, Evercore ISI Group maintained a 'buy' rating with a price target of $297. Barclays, on May 7, 2026, maintained a 'hold' rating with a target of $200. Other analysts, including JP Morgan and Citigroup, also maintained 'buy' ratings with targets of $280 and $245, respectively. The consensus among 22 analysts is a 'buy' recommendation, with a mean target price of $244.97.
About Astera Labs
Astera Labs, Inc. is a technology company that designs and manufactures semiconductor-based connectivity solutions for cloud and AI infrastructure. Headquartered in San Jose, California, the company serves hyperscalers and system original equipment manufacturers. It offers a range of products, including intelligent connectivity platforms, PCIe/CXL smart DSP retimers, and ethernet smart cable modules. Founded in 2017, Astera Labs is led by CEO Jitendra Mohan and employs about 756 people.
Bottom Line
The Canada Pension Plan Investment Board's substantial increase in Astera Labs shares highlights its confidence in the company's growth prospects. As a semiconductor firm, Astera Labs is well-positioned within the technology sector, which continues to see robust demand. The recent 13F filing provides a backward-looking view of CPPIB's holdings as of the reporting period, offering insight into its investment strategy.
Get Astera Labs, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ALAB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.